HAMEL ASSOCIATES, INC. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
HAMEL ASSOCIATES, INC. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$982,440
+0.9%
9,6450.0%0.36%
+5.3%
Q2 2023$973,277
+9.7%
9,6450.0%0.34%
+11.1%
Q1 2023$887,340
+1.3%
9,645
-0.1%
0.31%
+0.7%
Q4 2022$875,539
+19.3%
9,6510.0%0.30%
+5.2%
Q3 2022$734,000
-10.0%
9,6510.0%0.29%
-9.9%
Q2 2022$816,000
-11.4%
9,651
-8.0%
0.32%
-1.5%
Q1 2022$921,000
-26.3%
10,491
-26.6%
0.33%
-27.0%
Q4 2021$1,250,000
-62.7%
14,289
-65.1%
0.45%
-65.7%
Q3 2021$3,348,000
-26.0%
40,939
-17.4%
1.31%
-24.2%
Q2 2021$4,522,000
+4.7%
49,558
-1.9%
1.72%
+3.5%
Q1 2021$4,320,000
-12.9%
50,533
-3.8%
1.67%
-18.0%
Q4 2020$4,960,000
+7.4%
52,523
-1.1%
2.03%
-0.8%
Q3 2020$4,620,000
-0.0%
53,133
+0.4%
2.05%
-8.0%
Q2 2020$4,622,000
+5.2%
52,918
-0.7%
2.22%
-4.0%
Q1 2020$4,392,000
-12.4%
53,268
+0.5%
2.32%
+12.3%
Q4 2019$5,016,000
+7.6%
52,978
-1.2%
2.06%
+3.7%
Q3 2019$4,661,000
-5.3%
53,631
-0.5%
1.99%
-7.7%
Q2 2019$4,920,000
-5.8%
53,881
-0.8%
2.16%
-7.9%
Q1 2019$5,222,000
+12.5%
54,311
+0.4%
2.34%
+1.4%
Q4 2018$4,640,000
-0.4%
54,0760.0%2.31%
+14.5%
Q3 2018$4,659,000
+17.0%
54,076
+2.6%
2.02%
+10.4%
Q2 2018$3,981,000
-7.0%
52,701
-0.5%
1.83%
+537.3%
Q1 2018$4,282,000
-4.0%
52,961
-0.3%
0.29%
-86.4%
Q4 2017$4,461,000
-2.2%
53,136
+0.0%
2.11%
-5.1%
Q3 2017$4,561,000
+2.1%
53,126
-0.7%
2.22%
-1.2%
Q2 2017$4,468,000
+11.6%
53,526
-0.7%
2.25%
+10.3%
Q1 2017$4,003,000
+6.3%
53,901
+4.2%
2.04%
+5.0%
Q4 2016$3,767,000
-7.6%
51,710
+0.1%
1.94%
-10.1%
Q3 2016$4,079,000
-4.3%
51,6580.0%2.16%
-2.3%
Q2 2016$4,262,000
+27.8%
51,658
+12.2%
2.21%
+24.8%
Q1 2016$3,334,000
+9.5%
46,033
+30.0%
1.77%
-9.0%
Q4 2015$3,046,000
+2.8%
35,408
+9.9%
1.94%
-7.8%
Q3 2015$2,963,000
-7.0%
32,233
-0.5%
2.11%
+0.6%
Q2 2015$3,185,000
-4.1%
32,383
-3.8%
2.09%
-4.5%
Q1 2015$3,320,000
-0.7%
33,668
-6.7%
2.19%
+0.9%
Q4 2014$3,344,000
-1.6%
36,0930.0%2.17%
-4.1%
Q3 2014$3,398,000
+2.6%
36,093
-1.3%
2.26%
+3.7%
Q2 2014$3,311,000
+6.0%
36,568
-0.5%
2.18%
+1.0%
Q1 2014$3,124,000
+4.3%
36,743
-1.3%
2.16%
+3.0%
Q4 2013$2,994,00037,2432.10%
Other shareholders
NOVARTIS A G shareholders Q1 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders